)The top 100 stock
market authors
selected for publication
market authors
selected for publication
Beta Delta » Comments » Single Comment
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largestSee all
increase in followers
in the last 7 days
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most active
Instabloggers.-
1
David Fry
-
2
TraderMark
-
3
Don Dion
-
4
Cliff Wachtel
-
5
Mike Havrilla
Top Instabloggers » -
1
-
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
-
chris.. you forgot genentech's followup to the blockbuster drug Herceptin, now in multiple phase 2's and soon a pivotal P-3. Trastuzumab-dm1. This drug is a collaboration between
Aug 16 08:25 am
|Rating:
0
0
All Comments by Beta Delta »Genentech Pipeline: Too Good To Settle for Less? [View article]
DNA and IMGN
If the phase 2 data holds strong and it appears it will, TDM1 will greatly enhance the 4.5 billion in worldwide sales that Herceptin currently generates.